Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Single Blind, Attention Controlled, Multi-center Study of the Effects of a Rehabilitation Intervention on Participation Restrictions of Female Breast Cancer Survivors

NCT03915548 is registered in ClinicalTrials.gov with MGH Institute of Health Professions as lead sponsor.

NCT NCT03915548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03915548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Single Blind, Attention Controlled, Multi-center Study of the Effects of a Rehabilitation Intervention on Participation Restrictions of Female Breast Cancer Survivors
Lead sponsor
MGH Institute of Health Professions
Phase
Not applicable
Overall status
Completed
Start date
August 28, 2019
Completion date
March 31, 2024
Enrollment
303 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female